INOVIO PHARMACEUTICALS, INC. Earnings Per Share, Diluted in USD/shares from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2012 to Q3 2025.
  • Inovio Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2025 was -0.87 USD/shares, a 2.25% increase year-over-year.
  • Inovio Pharmaceuticals, Inc. Earnings Per Share, Diluted for the twelve months ending September 30, 2025 was -2 USD/shares, a 42.8% increase year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2024 was -3.95 USD/shares, a 35.1% increase from 2023.
  • Inovio Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2023 was -6.09 USD/shares, a 56.7% increase from 2022.
  • Inovio Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2022 was -14.1 USD/shares, a 19.4% increase from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)

INOVIO PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$2 -$1 +$0.02 +2.25% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 -$2 -$1 +$0.58 +48.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 -$3 -$1 +$0.80 +61.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 -$3 -$1 +$0.51 +47.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-18
Q3 2024 -$4 -$1 +$0.63 +41.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$5 -$1 +$0.42 +26.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 -$5 -$1 +$0.58 +30.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 -$6 -$1 +$12.00 +91.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-18
Q3 2023 -$18 -$2 -$1 -913% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$16 -$2 -$1 -250% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$15 -$2 -$2 -425% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$14 -$13 +$3.40 +20.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 -$17 $0 +$0.14 +48.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$17 $0 $0 -17.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$17 $0 $0 -33.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$17 -$17 -$16 -11686% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 -$1 $0 $0 -364% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $0 $0 +$0.44 +53% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$1 $0 $0 -3.85% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$1 $0 +$0.24 +63.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$1 $0.11 +$0.36 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$1 -$1 -$1 -177% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$1 $0 +$0.04 +13.3% Jan 1, 2020 Mar 31, 2020 10-K 2021-03-01
Q4 2019 -$1 $0 $0 -11.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$1 $0 +$0.02 +7.41% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$1 $0 $0 -275% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 $0 $0 +$0.06 +16.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$1 $0 $0 -41.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $0 $0 +$0.13 +32.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$1 $0 +$0.05 +38.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$1 $0 $0 -16.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$1 $0 +$0.12 +33.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$1 $0 $0 -42.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-12
Q2 2017 -$1 $0 +$0.13 +50% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-12
Q1 2017 -$1 $0 $0 -182% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-12
Q4 2016 -$1 $0 $0 -44% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 $0 $0 $0 -500% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-14
Q2 2016 $0 $0 $0 -189% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-14
Q1 2016 $0 $0 +$0.07 +38.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-14
Q4 2015 $0 $0 $0 -108% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $0 $0.07 +$0.19 Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 $0 $0 +$0.10 +52.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 $0 $0 +$0.02 +10% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 $0 $0 +$0.18 +60% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 $0 $0 +$0.52 +81.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$1 $0 +$0.05 +20.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$1 $0 +$0.03 +13% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$1 $0 Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$1 Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16

INOVIO PHARMACEUTICALS, INC. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4 +$2.14 +35.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 -$6 +$7.98 +56.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 -$14 +$3.38 +19.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 -$18 -$16 -1531% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 -$1 +$0.14 +11.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$1 $0 -15.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$1 +$0.04 +3.67% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$1 $0 -7.92% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$1 -$1 -130% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $0 +$0.20 +31.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 -$1 +$0.79 +55.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 -$1 -$1 -147% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$1 Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.